The Impact of Supportive Housing on Liver-Related Outcomes Among Persons With Hepatitis C Virus Infection

Abstract

Abstract Background Hepatitis C virus (HCV) infection disproportionately impacts people experiencing homelessness. Hepatitis C virus can lead to negative health outcomes, including mortality. We evaluated the impact of a permanent supportive housing (PSH) program (ie, “treatment”) on liver-related morbidity and mortality among persons with chronic homelessness and HCV infection. Methods We matched records for persons eligible for a New York City PSH program (2007–2014) with Heath Department HCV and Vital Statistics registries and Medicaid claims. Among persons diagnosed with HCV before or 2 years posteligibility, we added stabilized inverse probability of treatment weights to negative binomial regression models to compare rates for liver disease-related emergency department visits and hospitalizations, and hazard ratios for mortality, by program placement 2 and 5 years posteligibility. Results We identified 1158 of 8783 placed and 1952 of 19 019 unplaced persons with laboratory-confirmed HCV infection. Permanent supportive housing placement was associated with significantly reduced liver-related emergency department visits (adjusted rate ratio [aRR] = 0.76, 95% confidence interval [CI] = .61–.95), hospitalizations (aRR = 0.62, 95% CI = .54–.71), and all-cause (adjusted hazard ratio [aHR] = 0.65, 95% CI = .46–.92) and liver-related mortality (aHR = 0.72, 95% CI = .09–.83) within 2 years. The reduction remained significant for hospitalizations after 5 years. Conclusions Placement into PSH was associated with reduced liver-related morbidity and mortality among persons with HCV infection and chronic homelessness.